Cargando…
Pembrolizumab-induced focal segmental glomerulosclerosis: A case report
RATIONALE: Focal segmental glomerulosclerosis (FSGS) is the most common primary glomerular disorder that leads to end-stage kidney disease. Pembrolizumab, an immune checkpoint inhibitor, is an anti-programmed death 1 (PD-1) immunoglobulin G4 antibody approved for the treatment of advanced melanoma a...
Autores principales: | Kim, Da Woon, Jeon, Hakeong, Kim, Sungmi, Lee, Wanhee, Kim, Hyo Jin, Rhee, Harin, Song, Sang Heon, Seong, Eun Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556051/ https://www.ncbi.nlm.nih.gov/pubmed/34713828 http://dx.doi.org/10.1097/MD.0000000000027546 |
Ejemplares similares
-
Immunoglobulin A nephropathy in a patient with neurofibromatosis type 1: A case report and literature review
por: Rhee, Harin, et al.
Publicado: (2021) -
Collapsing focal segmental glomerulosclerosis in a patient with oral cavity cancer: A case report
por: Choi, Sae Byeol, et al.
Publicado: (2021) -
Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: A protocol of systematic review and meta-analysis of randomized controlled trials
por: Xue, Guozhong, et al.
Publicado: (2021) -
Effect of cyclosporine A on focal segmental glomerulosclerosis caused by MYO1E mutation in a Chinese adult patient: A case report
por: Li, Ruizhao, et al.
Publicado: (2023) -
Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study
por: Gu, Qiu-hua, et al.
Publicado: (2016)